• 1
    Parkin DM, Muir CS, Whelan SL, et al. Cancer Incidence in Five Continents, Vol. 6. Lyon: IARC Scientific Publications, 1992: 11728.
  • 2
    El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 74550.
  • 3
    Fernandez MP, Redvanly RD. Primary hepatic malignant neoplasms. Radiol Clin North Am 1998; 36: 33348.
  • 4
    Hong Kong Cancer Registry. Cancer Incidence and Mortality in Hong Kong 1995–1996. Hong Kong: Hong Kong Cancer Registry, 1997.
  • 5
    Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 1981; 2: 112933.
  • 6
    Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988; 61: 194256.
  • 7
    Sakuma K, Saitoh N, Kasai M, et al. Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective study. Hepatology 1988; 8: 16426.
  • 8
    Kato Y, Nakata K, Omagari K, et al. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer 1994; 74: 22348.
  • 9
    Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18: 4753.
  • 10
    Benvegnu L, Fattovich G, Noventa F, et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994; 74: 24428.
  • 11
    Kew MC, Houghton M, Choo QL, et al. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 1990; 335: 8734.
  • 12
    Colombo M, Kuo G, Choo QL, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2: 10068.
  • 13
    Bruix J, Barrera JM, Calvert X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatitis cirrhosis. Lancet 1989; 2: 10046.
  • 14
    Villeneuve JP, Desrochers M, Infante-Rivard C, et al. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 1994; 106: 10005.
  • 15
    McMahon BJ, Alberts SR, Wainwright RB, et al. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med 1990; 150: 10514.
  • 16
    Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995; 22: 4328.
  • 17
    Cottone M, Turri M, Caltagirone M, et al. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8 year prospective study by ultrasound and alphafetoprotein. J Hepatol 1994; 21: 102934.
  • 18
    Zoli M, Magolotti D, Bianchi G, et al. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 1996; 78: 97785.
  • 19
    Oka H, Tamori A, Kuroki T, et al. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994; 19: 616.
  • 20
    Borzio M, Bruno S, Roncalli M, et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis. A prospective study. Gastroenterology 1995; 108: 8127.
  • 21
    Pateron D, Ganne N, Trinchet JC, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994; 20: 6571.
  • 22
    Colombo M, De Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991; 325: 67580.
  • 23
    Zaman SN, Melia WM, Johnson RD, et al. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet 1985; 1: 135760.
  • 24
    Flickinger JC, Carr BI, Lotze MT. Cancer of the liver. In: DeVitaVT, HellmanS, RosenbergSA, eds. Cancer: Principles and Practice of Oncology, 5th edn. Philadelphia: Lippincott-Raven, 1997: 108797.
  • 25
    Stauss RM. Hepatocellular carcinoma: clinical diagnosis and therapeutic aspects. In: RustgiAK, ed. Gastrointestinal Cancers: Biology, Diagnosis and Therapy. Philadelphia: Lippincott-Raven, 1995: 47996.
  • 26
    Namieno T, Kawata A, Sato N, et al. Age-related, different clinicopathologic features of hepatocellular carcinoma patients. Ann Surg 1995; 221: 30814.
  • 27
    Nomura F, Ohnishi K, Honda M, et al. Clinical features of hepatocellular carcinoma in the elderly: a study of 91 patients older than 70 years. Br J Cancer 1994; 70: 6903.
  • 28
    Ng IO, Ng MM, Lai EC, et al. Pathologic features and patient survival in hepatocellular carcinoma in relation to age. J Surg Oncol 1996; 61: 1347.
  • 29
    Ou LH, Chau GY, Tsay SH, et al. Clinicopathological comparison of resectable hepatocellular carcinoma between the young and the elderly patients. Zhonghua Yi Xue Za Zhi (Taipei) 1997; 60: 407.
  • 30
    American Cancer Society. American Joint Committee on Cancer. AJCC Cancer Staging Manual, 5th edn. Philadelphia: Lippincott-Raven, 1997.
  • 31
    Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001; 234: 6370.
  • 32
    Poon RT, Fan ST, Lo CM, et al. Hepatocellular carcinoma in the elderly: results of surgical and non-surgical management. Am J Gastroenterol 1999; 94: 24606.
    Direct Link:
  • 33
    McMahon BJ, London T. Workshop on screening for hepatocellular carcinoma. J Natl Cancer Inst 1991; 83: 9169.
  • 34
    Colombo M. Early diagnosis of hepatocellular carcinoma in Italy. A summary of a Consensus Development Conference held in Milan, 16 November 1990 by the Italian Association for the Study of the Liver (AISF). J Hepatol 1992; 14: 4013.
  • 35
    Tabor E. Strongly supported features of the association between hepatitis B virus and hepatocellular carcinoma. In: TaborE, Di BisceglieAM, PurcellRH, eds. Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. The Woodlands, TX: Portfolio, 1991: 10717.
  • 36
    McMahon BJ, Bulkow L, Harpster A, et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B. A 16-year population-based study. Hepatology 2000; 32: 8426.
  • 37
    Lok A, McMahon BJ. Chronic hepatitis B. Hepatology 2001; 34: 122547.
  • 38
    De La Monte SM, Hutchins GM, Moore GW. Influence of age on the metastatic behavior of breast carcinoma. Hum Pathol 1988; 19: 52934.
  • 39
    Recalde M, Holyoke ED, Elias EG. Carcinoma of the colon, rectum, and anal canal in young patients. Surg Gynecol Obstet 1974; 139: 90913.
  • 40
    Wan J, Grossman HB. Bladder carcinoma in patients aged 40 years or younger. Cancer 1989; 64: 17881.
  • 41
    Shaha AR, Shah JP, Loree TR. Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol 1996; 3: 5348.
  • 42
    Ni YH, Chang MH, Hsu HY, et al. Hepatocellular carcinoma in childhood. Clinical manifestations and prognosis. Cancer 1991; 68: 173741.